HealthMore in Health→
Ulcerative Colitis Study Identifies Treatment Response Patterns
Key Takeaways
- Analysis of 768 trial participants identified four response-trajectory groups.
- A second trial of 576 participants linked vedolizumab trajectories to long-term complications.
- Researchers say prospective validation is required before clinical use.
DE
DT Editorial Team··via nature.com